Yong'an Pharmaceutical: Intends to Acquire 27 Million Yuan to Acquire Minority Shareholders' Equity of a Subsidiary

Yongan Pharmaceutical announced that the company plans to use its own funds of 27 million yuan to acquire a 49.20% stake in Ling'an Technology held by minority shareholders Zhang Yong, Xia Changpei, and Dai Liang. This move aims to further strengthen the control of Ling'an Technology, accelerate its market layout in the business field, and align with the company's overall strategic planning. After the transaction is completed, Ling'an Technology will become a wholly-owned subsidiary of the company. The source of funds for this transaction is from the company's own funds and will not affect the normal production and operation of the company.